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ABSTRACT
In S. mutans, the expression of the surface glycoprotein Cnm mediates binding to extracellular matrix
proteins, endothelial cell invasion and virulence in the Galleria mellonella invertebrate model. To further
characterize Cnm as a virulence factor, the cnm gene from S. mutans strain OMZ175 was expressed in the
non-pathogenic Lactococcus lactis NZ9800 using a nisin-inducible system. Despite the absence of the
machinery necessary for Cnm glycosylation, Western blot and immunofluorescence microscopy analyses
demonstrated that Cnm was effectively expressed and translocated to the cell wall of L. lactis. Similar to
S. mutans, expression of Cnm in L. lactis enabled robust binding to collagen and laminin, invasion of
human coronary artery endothelial cells and increased virulence in G. mellonella. Using an ex vivo human
heart tissue colonization model, we showed that Cnm-positive strains of either S. mutans or L. lactis
outcompete their Cnm-negative counterparts for tissue colonization. Finally, Cnm expression facilitated L.
lactis adhesion and colonization in a rabbit model of infective endocarditis. Collectively, our results
provide unequivocal evidence that binding to extracellular matrices mediated by Cnm is an important
virulence attribute of S. mutans and confirm the usefulness of the L. lactis heterologous system for further
characterization of bacterial virulence factors.
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Introduction
The association of Streptococcus mutans with dental car-
ies, the most prevalent and costly infectious disease
worldwide, is well established.1,2 The capacity of S.
mutans to form biofilms in the presence of sucrose, to
produce organic acids upon fermentation of dietary car-
bohydrates, and to tolerate large fluctuations in pH are
considered the major cariogenic traits of this bacte-
rium.3,4 However, the medical implications of S. mutans
are not limited to the oral cavity as this organism can
cause extra-oral infections and may play an important
and underestimated role in the onset of cardiovascular
diseases.5-9 This facet of S. mutans pathogenesis is likely
associated with its ability to interact with extracellular
matrix (ECM) components such as collagen, which ena-
bles colonization of different host tissues.10,11
Infective endocarditis (IE) is a life-threatening bacte-
rial infection of the endocardium with approximately
45,000 occurrences per year in the US12 and mortality
rates around 15–20%.9,13,14 Along with staphylococci
and enterococci, viridans streptococci (VS) are a major
bacterial group associated with IE,12 and S. mutans is
estimated to account for »20% of all VS-associated IE
cases.9,15 In addition, S. mutans DNA has been detected
at a high frequency in cardiovascular tissues from
patients that underwent valve replacement surgery and
atherosclerotic plaque removal.16,17 Yet, the mechanisms
employed by S. mutans to colonize and persist in human
heart tissues are still poorly understood.
The S. mutans surface protein Cnm is a collagen- and
laminin- binding glycoprotein shown to mediate adhe-
sion to collagen and laminin, invasion of endothelial
cells, and virulence in an invertebrate model.18-20 Epide-
miological studies have shown that cnm is present in
approximately 15% of S. mutans isolates, being found at
higher frequency among serotype e, f and k strains but
rarely present in serotype c strains.18,21-23 Interestingly,
isolates of S. mutans that belong to serotypes e, f and k
CONTACT Jacqueline Abranches jabranches@dental.ufl.edu Department of Oral Biology, 1395 Center Drive, Box 100424, University of Florida College
of Dentistry, Gainesville, FL 3261, USA.
Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/kvir.
© 2017 Taylor & Francis
VIRULENCE
2017, VOL. 8, NO. 1, 18–29
http://dx.doi.org/10.1080/21505594.2016.1195538
are rare in the oral cavity but commonly detected in
patients with IE, atherosclerosis and other systemic
infections.1,22 Moreover, in vivo and cross-sectional stud-
ies suggest an association between S. mutans serotypes e,
f and k expressing Cnm and extra-oral pathologies such
as hemorrhagic stroke, cerebral microbleeds and non-
alcoholic steatohepatitis,5,6,24 indicating that Cnm may
contribute to the pathogenic potential of S. mutans dur-
ing systemic infections.
The Gram-positive bacterium Lactococcus lactis is a
non-pathogenic organism used in the dairy industry for
the production of fermented milk products.25 In addi-
tion, L. lactis is used for the production of heterologous
proteins,26 and in live mucosal vaccines.27 The presence
of secretory and protein anchoring enzymes (e.g. SecA
and SrtA) combined with the low number of genes
encoding secreted and surface-anchored proteins makes
L. lactis a desirable host for the characterization of sur-
face virulence factors of pathogenic Gram-positive bacte-
ria.26,28-30 For example, systemic or mucosal delivery of a
recombinant L. lactis strain expressing the Streptococcus
agalactiae pilus 1 genes was shown to protect mice from
subsequent challenges with S. agalactiae.31 Other bacte-
rial proteins successfully expressed in L. lactis include
Staphylococcus aureus clumping factor A (ClfA) and
fibronectin-binding protein A (FnBPA),30 Staphylococcus
epidermidis SdrF,32 and Listeria monocytogenes LnlA.33
In each of these studies, heterologous expression of these
foreign factors was sufficient to increase the pathogenic
potential of this otherwise harmless microorganism.
Here, the contribution of Cnm to bacterial virulence was
further investigated using the L. lactis heterologous
expression system. Our results provide unequivocal evi-
dence that Cnm is a major virulence factor of S. mutans
that contributes to systemic infections.
Results
Optimization of Cnm expression in L. lactis
After successful electroporation of pMSP3535::cnm into L.
lactis NZ9800, the concentration of nisin that conferred
optimal expression of Cnm without causing growth inhib-
itory effects was determined. The growth of L. lactis was
only noticeably affected at 25 ng ml¡1nisin or higher con-
centrations (data not shown). Western blot analysis
showed a concentration-dependent induction of Cnm
from pMSP3535::cnm by nisin with strong induction
observed at 10 ng ml¡1 and above (Fig. 1A). Non-induced
cultures of L. lactis pMSP3535::cnm showed basal expres-
sion of Cnm, which is in line with previous reports dem-
onstrating that the pMSP3535 system is leaky.34,39
Immunofluorescence labeling of intact cells confirmed
expression and surface localization of Cnm (Fig. 1B).
Based on these results, we chose 10 ng ml¡1nisin for all
subsequent experiments as it yielded robust protein pro-
duction without interfering with cell growth.
As previously determined in S. mutans, L. lactis Cnm
migrates as a higher molecular weight protein on SDS-
PAGE (»90 kDa) compared to its predicted size of
54 kDa (Fig. 2). This version of Cnm corresponds to the
unglycosylated variant, which in S. mutans displays
increased susceptibility to proteinase K degradation.19
Similar to unglycosylated Cnm from S. mutans, Cnm
expressed by L. lactis was rapidly and completely
degraded upon proteinase K treatment (Fig. 2). Nonethe-
less, unglycosylated Cnm in S. mutans retains its func-
tional capacities,19 thus we proceeded with the
characterization of Cnm-mediated phenotypes in L. lactis.
CnmC L. lactis binds to ECM and invades HCAEC
The ability of the recombinant L. lactis CnmC strain to
bind to collagen and laminin in vitro was tested. When
compared to the parent strain NZ9800 hosting the empty
vector, expression of Cnm from pMSP3535::cnm led to
robust binding to both collagen and laminin (Fig. 3A and
B, respectively). In accordance with our expression analy-
sis (Fig. 1), uninduced pMSP3535::cnm produced low lev-
els of Cnm and therefore enabled the recombinant L.
lactis strain to bind to both ECM proteins, albeit at lower
levels than nisin-induced cells (P < 0.05). To further
demonstrate that the ability to bind to collagen is medi-
ated by Cnm, we performed the collagen-binding assay in
the presence of anti-rCnmA antibody. As expected, co-
incubation of L. lactis cells expressing Cnm with anti-
rCnmA antibodies led to significant inhibition of collagen
binding activity compared to L. lactis incubated with pre-
immune serum (Fig. 3C). In agreement with increased
collagen and laminin binding activities observed for nisin-
induced cells, expression of Cnm enabled L. lactis to
invade HCAEC (Fig. 3D). While ECM binding was
observed in uninduced cultures, HCAEC invasion levels
were negligible in the absence of nisin (P > 0.05).
Expression of Cnm mediates adherence to aortic
valve tissues ex vivo
To determine if Cnm bestows an enhanced heart tissue
binding capacity to either S. mutans or L. lactis ex vivo,
competition binding assays were performed using freshly
extirpated human aortic valve tissues. In agreement with
the ECM-binding in vitro data, the S. mutans OMZ175
and nisin-induced CnmC L. lactis strains outcompeted
their Cnm¡ counterparts by approximately 10 and 100-
fold, respectively (Fig. 4). In these experiments, the
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recovered CFUs were on average an order of magnitude
higher for S. mutans and L. lactis CnmC strains (1.7 £
105 and 3.9 £ 105 CFU ml¡1, respectively) compared to
Cnm¡ strains (1.7 £ 104 and 2.7 £ 104 CFU ml¡1,
respectively). Scanning electron microscopy (SEM) of
tissues infected for 90 min with monocultures of L. lactis
(Fig. 5) or S. mutans (data not shown) confirmed that
only CnmC strains could effectively bind to the collage-
nous fibrils of damaged valve tissues (Fig. 5A). Moreover,
while we cannot exclude the possibility that ECM
components from heart valves became exposed during
sample manipulation, SEM analysis revealed that CnmC
strains could also adhere to tissue areas where no appar-
ent damage can be observed (Fig. 5B).
Cnm contributes to virulence in galleria mellonella
The ability of the L. lactis strains to kill the larvae of G. mel-
lonella, a model of systemic infection, was assessed. As
shown in Figure 6, the mortality rates of G. mellonella were
Figure 2. L. lactis expresses unglycosylated, proteinase K susceptible Cnm. Whole cells from S. mutans OMZ175, DpgfS and nisin-induced
L. lactis pMSP3535::cnm were treated with 30 mg ml¡1 of proteinase K for 30 min. After treatment, whole-cell lysates were prepared and
Cnm degradation was monitored by protein gel blot using anti-rCnmA.
Figure 1. Expression of Cnm from pMSP3535::cnm in recombinant L. lactis. (A) Western blot analysis of protein lysates was performed
with a polyclonal antibody specific to Cnm. A nisin concentration-dependent induction of Cnm was observed from pMSP3535::cnm, and
the uninduced culture showed basal protein expression. (B) Immunofluorescence labeling analysis revealing Cnm expression on the sur-
face of L. lactis.
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significantly higher in larvae infected with the CnmC strain
compared to those infected with the wild-type strain har-
boring the empty vector control (P < 0.05). Remarkably
when considering the extremely low virulence potential of
L. lactis, the recombinant CnmC strain showed a similar
pattern of killing when compared to the CnmC S. mutans
OMZ175 strain.
Cnm contributes to endocardium adherence in vivo
A rabbit model of IE38 was employed to examine the
effect of Cnm expression on L. lactis adherence to endo-
cardium and vegetations. In one experiment, a mixed
inoculum of NZ9800 (pCIE) and NZ9800 (pMSP3535::
cnm) was injected into rabbits intravenously 1 h after sur-
gery. Two hours later, the rabbits were euthanized and
the hearts removed. This time was chosen so as to allow
enough time for clearance of bacteria from the blood-
stream,40 but not so long as to have excessive loss of Cnm
due to growth without nisin. Catheters were clamped into
place during necropsy to preserve their positions. At this
early stage, vegetations were not visible, and the entire
endocardial surface in apparent contact with the catheter
was excised and homogenized. Following sonication, both
the mixed inoculum and the homogenates were plated on
selective media to determine strain ratios. In the second
experiment, animals were inoculated 2 d after surgery.
Vegetations, which were visible in all animals, were
removed and homogenized. Because vegetations are com-
posed primarily of platelets and fibrin rather than colla-
gen,41 the endocardium beneath each vegetation was also
collected, homogenized, and plated separately. As shown
Figure 3. Cnmpromotes binding to ECM proteins and invasion of endothelial cells. (A and B) Binding of bacterial cells to extracellular matrix pro-
teins: (A) collagen type I and (B) laminin. (C) Inhibition of binding to collagen type I by anti-rCnmA antibody (1:20). (D) HCAEC invasion assay
showing the normalized percentage of invasion for each strain after 3 h of co-incubation (P< 0.05, P< 0.01, P< 0.0001, ANOVA followed
by Tukey’s post-test). The S. mutans OMZ175 (CnmC) strain was used as a positive control in all assays. The symbols “C” and “¡“ in the graphs
denote induction or no induction with nisin, respectively.
Figure 4. Expression of Cnm mediates bacterial adherence to aor-
tic valve sections. A competition assay was developed to test the
contribution of Cnm toward bacterial adherence to human aortic
valves ex vivo. A 1:1 mixed infection of the valve sections was
allowed for 90 min using CnmC and Cnm¡ strains. The competi-
tive index (CI) was calculated based on the initial inocula, where
a value of “D1” represents no difference and “>1” represents
preferred binding by the numerator strain. #P < 0.05
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in Figure 7, the CI value of the cells harvested from the
endocardium were similar in animals inoculated 1 hour
or 2 d after catheterization (geometric mean D 1.68 and
1.66, respectively), indicating a »67% increase in infectiv-
ity of the Cnm-expressing strain relative to the control
strain. These values were significantly greater from 1.0 —
the value indicating no change in infectivity — whether
the 2 experiments were analyzed separately or together. In
contrast, there was no significant difference in the CI
value for bacteria recovered from vegetations.
Figure 5. Cnm mediates binding to the collagenous fibrils of damaged and apparently undamaged infected human valve sections. SEM
analysis of valve sections incubated with bacterial monocultures showed CnmC L. lactis binding to bundles of collagenous fibrils on the
rough edges of the valves whereas no Cnm¡ L. lactis were found attached to this area (A). CnmC L. lactis could also adhere to tissue
areas where no apparent damage was observed in contrast with their Cnm¡ counterparts (B).
Figure 6. Cnm contributes to virulence in the G. mellonella systemic infection model. The Kaplan-Meier curves indicate the percent sur-
vival at selected intervals of larvae infected with S. mutans OMZ175 and L. lactis strains for 96 h. The mortality rates of G. mellonella
were significantly higher in larvae infected with CnmC L. lactis compared to those infected with the wild-type NZ9800 harboring the
empty vector control (pMSP3535) (P < 0.05).
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Discussion
The presence of Cnm has been correlated with an
increased ability of S. mutans to invade and persist intra-
cellularly, and to cause disease.6,18,20,21,42,43 In the present
study, by expressing Cnm in the non-pathogenic L. lactis
host we provided unequivocal evidence that Cnm con-
tributes to bacterial virulence.
Various properties of L. lactis have justified its
attractiveness for heterologous expression of surface
proteins. For instance, the fermentative metabolism of
L. lactis is relatively simple and well known, the
genomes of various strains are available and known to
encode a very low number of genes encoding secreted
and surface-anchored proteins.25,44,45 Here, we showed
that Cnm expression increased the ability of L. lactis
to bind to type I collagen and laminin in vitro, adhere
to aortic valve tissues ex vivo, and colonize endocardial
surfaces in vivo. Of note, type I collagen is the most
abundant ECM component in human46,47 and rabbit48
aortic valves. Although ex vivo experiments cannot
reproduce the immunologic responses and constant
shear force of blood flow, our findings highlighted the
contribution of Cnm in binding of organisms to colla-
gen-rich tissues in both humans and rabbits. Also,
while we observed higher levels of ECM binding and
virulence G. mellonella by CnmCL. lactis compared to
S. mutans OMZ175, during this study we restrained
ourselves from making direct comparisons as these
species possess fundamental differences that may affect
Cnm-dependent phenotypes (e.g., Cnm expression lev-
els, additional surface proteins, growth conditions).
Recently, our group reported that Cnm is a glycopro-
tein and identified the glycosylation machinery (Pgf)
responsible for its post-translational modification. In
SDS-PAGE, the native Cnm migrates at approximately
120 kDa whereas the variant from the deletion of the
pgfS gene was found to migrate at »90 kDa.19 When
analyzed by Western blot, the Cnm variant produced by
L. lactis was found to migrate at »90 kDa, the same size
as the unglycosylated version of Cnm produced in S.
mutans.19 Moreover, like the unglycosylated Cnm pro-
duced by the DpgfS strain in S. mutans, the Cnm
expressed by L. lactis was highly susceptible to proteinase
K degradation.19 These findings are supported by in silico
analysis that indicated the absence of Pgf homologs in
the available genomes of L. lactis. Most importantly, the
lack of Cnm glycosylation may explain the difference in
adhesion between endocardial tissue in vivo and ECM-
binding in vitro or ex vivo. Whether this difference is
due to the considerable shear forces and host proteases
present in the in vivo model, or to some other factor(s)
remains to be determined. However, we hypothesize that
L. lactis expressing glycosylated Cnm will show further
increased levels of binding in vitro, ex vivo and, possibly,
in vivo. Expression of Cnm had no effect on colonization
of preexisting vegetations, which is not surprising con-
sidering these vegetations are composed primarily of pla-
telets and fibrin.41 Nevertheless, adhesins for collagen
and other matrix proteins have been identified previ-
ously as virulence factors for IE.29,49,50 As with these
other adhesins, Cnm may allow adherence to damaged
endocardium prior to vegetation formation, thereby pro-
viding another route for infection in IE.51 The increased
adherence to endocardium observed is also consistent
with previous reports of association of Cbm-expressing
strains, with both IE and non-IE cardiovascular
diseases.7,52
Collectively, our results clearly show that expression
of Cnm alone confers virulence to an otherwise non-
pathogenic bacterium, and promotes bacterial adherence
to cardiac tissue in vivo and ex vivo. Thus, Cnm could be
considered a target for the development of antimicrobial
strategies to mitigate virulence of invasive S. mutans
strains.
Figure 7. Cnm contributes to bacterial endocardium adherence
in vivo. Rabbits (nD3) were co-inoculated with Cnm-expressing
and control L. lactis strains 1 hour or 2 days after insertion of an
intracardiac catheter as indicated and then sacrificed 2 hours
later. Bacteria were recovered from endocardial surfaces (End.),
and in the 2-day samples, from adjacent vegetations (Veg.). CI
values (for L. lactis CnmC over L. lactis Cnm¡) are indicated for
each sample, with geometrical mean CIs indicated by a horizontal
line. Means significantly different from 1.0 (dashed line) are indi-
cated: P < 0.05; P < 0.001. Like symbols in the 2-day experi-
ment indicate samples recovered from the same animal. Red
circle, sample from which one of the 2 strains was not recovered
(L. lactis Cnm¡); the limit of detection was used for the
calculation.
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Material and methods
Bacterial strains and growth conditions
All strains used in this study are listed in Table 1. The L.
lactis strains were routinely cultured aerobically at 30C
in M17 broth (Difco) supplemented with 0.5% (w/v) glu-
cose (GM17). When necessary, 10 mg ml¡1 erythromy-
cin or 15 mg ml¡1 chloramphenicol (Sigma-Aldrich) was
added to the growth media (GM17-Erm or GM17-Chlor,
respectively). The S. mutans strains were routinely cul-
tured in brain heart infusion (BHI) medium at 37C in a
5% CO2 atmosphere.
Expression of Cnm in L. lactis
The nisin-inducible plasmid pMSP353534 harboring the
cnm gene (pMSP3535::cnm) from S. mutans OMZ175,21
was used to express Cnm in L. lactis. The pMSP3535::
cnm plasmid as well as the empty pMSP3535 vector 34
and the pCIE plasmids (Dunny et al., unpublished) were
electroporated into L. lactis NZ9800 as detailed else-
where 35 with some modifications. The pCIE plasmid,
conferring resistance to chloramphenicol, was generated
from shuttle plasmid pCI13340 36 and introduced into L.
lactis for selection purposes in competition assays.
Briefly, cells were grown overnight at 30C in M17 broth
supplemented with 0.5% glucose (GM-17) and sub-cul-
tured (1:100) in fresh GM-17 containing 1% glycine and
0.5 M sucrose (GM17S). The culture was grown to
OD600 of 0.2, centrifuged at 5,000 rpm for 10 min at 4C
and washed 3 times with cold electroporation buffer
(EB) (0.5 M sucrose, 1 mM MgCl2, 7 mM K2HPO4-
KH2PO4 [pH 7.4]). Electrocompetent cells were resus-
pended in EB, quickly frozen on dry ice/ethanol bath
and stored at ¡80C until use. A micro-pulser electropo-
ration apparatus (Bio-Rad Laboratories) (0.1cm cuvette,
1.4 kV, 600 V, 10 mF) was used to electroporate the
desired plasmids into L. lactis. After electroporation, cells
were incubated in GM17S for 3 h at 30C and spread on
GM17 plates containing the desired antibiotic. Resulting
colonies were screened for the presence of the desired
plasmid by PCR. For induction of Cnm, cells were grown
overnight in GM17-Erm in the presence of increasing
concentrations of nisin (Sigma-Aldrich). The production
and cell surface localization of Cnm was confirmed by
Western blotting and by immunofluorescence labeling as
detailed below.
Western blot (WB) analysis
Overnight cultures of S. mutans OMZ175 and recombi-
nant L. lactis strains were used to prepare protein lysates
by homogenization with 0.1 mm glass beads using a
bead beater (Biospec). Protein lysates were separated on
a 10% SDS-PAGE and transferred to a polyvinylidene
fluoride (PVDF) membrane (Millipore) using standard
protocols. The presence of Cnm was detected using rab-
bit anti-rCnmA polyclonal antibody 19 diluted 1:2000 in
1 x phosphate buffered saline (PBS) with 0.1% Tween
20 pH 7.2 and anti-IgG (goat anti-rabbit) horseradish
peroxidase-coupled antibody diluted 1:10000 (Sigma-
Aldrich). Membranes were developed using an enhanced
chemiluminescent detection kit (GE Life Sciences).
Proteinase K susceptibility assay
The susceptibility of Cnm to protease degradation was
assessed as described previously.19 Briefly, overnight cul-
tures of S. mutans OMZ175, DpgfS and nisin-induced L.
lactis pMSP3535::cnm were pelleted and resuspended in
1x PBS pH 7.4 containing 30 mg ml¡1 of proteinase K
(Sigma-Aldrich). After 30 min incubation on ice, prote-
ase activity was neutralized with the addition of 1x prote-
ase inhibitor cocktail (Thermo Scientific). Bacterial cells
were then washed once with PBS, and Cnm stability was
analyzed by western blotting.
Immunofluorescence labeling of Cnm
Cultures of recombinant L. lactis and S. mutans OMZ175
were used for cellular localization of Cnm. Cells grown to
mid-exponential phase were washed in PBS and incu-
bated in the presence of anti-rCnmA antibody (1:100)
followed by anti-rabbit Alexa-488 conjugate antibody
(1:100) with 3 washes between each antibody exposure.
Cell-antibody complexes were visualized using an Olym-
pus BX41 fluorescent microscope and images were cap-
tured with the QCapture Software.
Binding to extracellular matrix (ECM) proteins
Collagen and laminin binding assays were performed as
previously described.20,21 Briefly, 96-well plates were
Table 1. Strains used in this study.
Strain Relevant phenotype Reference
Streptococcus mutans
OMZ175 CnmC Lab collection
OMZ175 (pBGE) CnmCErmr (21)
Dcnm DpgfS Cnm¡ KanrCnmC Kanr (21) (19)
Lactococcus lactis subsp. lactis
NZ9800 WT, Cnm¡ Lab collection
NZ9800 (pMSP3535) Cnm¡Ermr This study
NZ9800 (pMSP3535::cnm) CnmCErmr This study
NZ9800 (pCIE) Cnm¡, Chlorr This study
Note. WT (wild type); Kan (kanamycin); Erm (erythromycin); Chlor
(chloramphenicol).
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coated with 40 mg ml¡1 type I collagen from rat tail
(Sigma-Aldrich), or 50 mg ml¡1 mouse laminin (Becton-
Dickinson) for 18 h at 4C. Individual wells were washed
and blocked with 5% bovine serum albumin for 1 h at
37C. Overnight bacterial cultures were washed twice in
PBS and 100 ml aliquots of each bacterial suspension
added to the wells, followed by incubation for 3 h at
37C. Loosely bound bacteria were removed by washing
with PBS and adhered cells were stained with 0.05% crys-
tal violet solution and then quantified at 575 nm. Experi-
ments were also performed with bacteria pre-incubated
with anti-rCnmA antibody (1:20 dilution in PBS) for
30 min before incubation with collagen. To confirm the
requirement of Cnm in collagen binding, experiments
were performed as described above but bacteria were
pre-incubated with anti-rCnmA or pre-immune serum
(1:100) for 30 min before exposure to collagen.19
Invasion of human coronary artery endothelial cells
(HCAEC)
Cultivation of primary HCAECs and invasion assays
were performed as previously described.18,21 The
HCAEC monolayer was incubated with 1 ml of 2% fetal
bovine serum (FBS)-endothelial basal medium (EBM-2)
containing 1-2 £ 107 CFU ml¡1 of S. mutans OMZ175
or Dcnm, or recombinant L. lactis strains for 2 h at a
multiplicity of infection of 100:1, followed by 3 h of incu-
bation in 2% FBS-EBM-2 medium containing 300 mg
ml¡1gentamicin and 50 mg ml¡1 penicillin G to kill
extracellular bacteria. After incubation with antibiotics,
HCAEC were lysed with 1 ml of sterile water and the
mixture of lysed HCAEC and bacteria serially diluted
and plated onto tryptic soy agar (TSA) plates to deter-
mine the number of intracellular bacteria. The percent-
age of invasion for each strain was calculated based on
the total colony forming units (CFU) number present in
the initial inoculum and the number of intracellular bac-
teria recovered from HCAEC lysates.
Adherence to human cardiac valve sections ex vivo
The ability of S. mutans and L. lactis strains to bind to
human aortic valve tissues ex vivo was assessed by adapt-
ing a protocol originally described for porcine heart tis-
sues.37 Human aortic valve tissues were obtained from
patients undergoing valve replacement surgery due to
calcific stenosis (Institutional Review Board protocol no.
RSRB00053016, University of Rochester). Valvular tis-
sues with no signs of calcification, bleeding or inflamma-
tion were selected and 3-mm diameter valve sections
were obtained using a biopsy punch tool (Acuderm).
Valve sections were incubated overnight in 12-well plates
with endothelial cell medium (ECM) supplemented with
5% FBS, 1000 mg L¡1 hydrocortisone, 12 mg L¡1 bovine
brain extract, 0.1% human recombinant epidermal
growth factor (Lonza) plus 300 mg ml¡1 gentamicin. On
the following day, sections were washed twice with
Hank’s Balanced Salt Solution (HBSS, Corning Inc.) to
remove residual antibiotic and then transferred to a new
plate. A competition assay was then performed to deter-
mine the capacity of CnmC strains to compete with
Cnm¡ strains. For this, valve sections were infected with
approximately 5 £ 107 CFU ml¡1 of a 1:1 suspension of
CnmC and Cnm¡strains bearing distinct antibiotic
markers for CFU determination of each strain. Plates
were incubated for 90 min at 37C (for S. mutans) or
30C (for L. lactis) with gentle rocking. Valve sections
were transferred to sterile centrifuge tubes containing
1 ml of HBSS and vigorously agitated 3 times for 5 sec-
onds using a vortex to remove loosely bound bacteria
from the tissues. Washed valve sections were homoge-
nized in 500 ml PBS for 2 min using a motorized pestle
(Fisher Scientific), serially diluted and plated onto TSA
plates with the corresponding antibiotics. The competi-
tive index (CI) was calculated based on the CFUs present
in the initial inoculum and the final enumeration of bac-
teria recovered from the tissue.
Scanning electron microscopy (SEM) analysis of
valve sections
To visualize bacterial attachment to heart valve sections,
tissue samples were prepared and incubated in the pres-
ence of 5 £ 107 CFU ml¡1 S. mutans or L. lactis mono-
cultures as described in the previous section. Valve
samples were washed and fixed with 4% paraformalde-
hyde, 2.5% glutaraldehyde and 0.1 M sodium cacodylate
for 2 d at 4C, with slow rocking. The samples were ana-
lyzed using a Zeiss-Auriga focused ion beam field emis-
sion scanning electron microscope (FIB-FE-SEM) and
the images captured using the attached Gatan
Erlangshen digital camera at the University of Rochester
Medical Center Electron Microscopy Core Facility.
Galleria mellonella infection
The systemic infection of G. mellonella has been previ-
ously detailed elsewhere.19,21 Briefly, 5 ml aliquots con-
taining 1-1.5x106 CFU of S. mutans OMZ175 (positive
control), or recombinant L. lactis were injected in the
larvae hemocoel via the last left proleg. Larvae injected
with heat-killed bacteria (45 min, 80C) were used as
negative controls. After injection, larvae were kept in the
dark at 37C, and survival was periodically monitored
for up to 4 d.
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In vivomodel of infective endocarditis in rabbits
The rabbit model of IE employed for this study was modi-
fied from a previously used protocol.38 Specific-pathogen-
free, male New Zealand White Rabbits 2 to 3 kg in size
were purchased from Robinson Services Inc. After acclima-
tion, rabbits were injected with acepromazine as a sedative,
a cocktail of ketamine, xylazine, and buprenorphine for
general anesthesia, glycopyrrolate for control of respiratory
secretions, and bupivacaine at the incision site. An incision
was then made in the neck region, and a 19-gauge catheter
(Intracath, BD Bioscience) was inserted through the right
internal carotid artery, contacting or passing through the
aortic valve to cause minor damage. The catheter was tied
off, trimmed, and sutured into place, and the incision
closed. Buprenorphine SR Lab was used for post-surgical
analgesia. The day prior to inoculation, L. lactis strains
were cultured overnight in GM17 and antibiotics as
described above with 10 ng ml¡1 nisin. Twenty hours later,
the cultures were diluted 10-fold into pre-warmed media of
the same composition and cultured another 3 h. Cells were
harvested by centrifugation, washed twice with cold PBS,
diluted in PBS, and combined to achieve a concentration of
3 – 5£ 108 CFUml¡1 for each strain. One hour or 2 d after
the surgeries, rabbits were inoculated with 0.5 ml of bacte-
rial cells via a peripheral ear vein. Remaining cells were son-
icated for 1.5 min at 50% power in a Biologics Model 150
sonicator (Biologic Inc.) to break up clumps and chains
and plated with an Eddy Jet spiral plater (Neutec Group
Inc.) on GM17 plates containing erythromycin or chloram-
phenicol to establish the ratio of the 2 strains in the inocu-
lum. Two hours after inoculation, each rabbit was
euthanized with intravenous Euthasol (Virbac) and was
then checked for proper placement of the catheter tip in the
valve region or beneath it in the left ventricle. Any rabbit in
which the catheter was not correctly situated was excluded
from the study. For rabbits inoculated on the day of sur-
gery, the aortic valves and surrounding endocardium were
removed and homogenized in 5 ml PBS using an electric
homogenizer (Omni International). For rabbits inoculated
2 d post-surgery, visible vegetations and the endocardium
underlying each vegetation were harvested separately and
homogenized in 2 ml PBS each using a disposable 15-ml
tissue grinder. In all cases, homogenates were sonicated and
plated as above for enumeration.
Statistical analysis
All results represent a minimum of 3 independent
experiments. Descriptive and inferential statistics were
used to analyze the data on Graphpad Prism version
5.0. One-way ANOVA followed by Tukey’s post-test
was used to analyze the significance of binding and
invasion, with type I error set as 0.05. Analysis of
log10-transformed competitive indices was performed
using one-way ANOVA with Bonferroni post hoc com-
parisons to determine substrate preferences among
strain pairs. For the G. mellonella studies, Kaplan-
Meier killing curves were plotted and estimation of
differences in survival was compared using the log-
rank test. Log10-transformed competitive indices were
compared to 0 using a one-sample T test for rabbit
studies.
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glucose plus erythromycin or chloram-
phenicol (Chlor)
GM17S GM-17 containing 1% glycine and
0.5 M sucrose
HBSS Hank’s balanced salt solution
HCAEC human coronary artery endothelial cells
IE infective endocarditis
PVDF polyvinylidene fluoride
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